This page is part of the FHIR Specification (v5.0.0-ballot: FHIR R5 Ballot Preview). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions
Clinical Decision Support Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Not linked to any defined compartments |
This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile EvidenceVariable.
Generated Narrative: EvidenceVariable
Resource EvidenceVariable "example-eligibility-criteria-diabetes-surgery"
identifier: FEvIR Object Identifier: 32120
title: StudyEligibilityCriteria: Eligibility Criteria for Bariatric Surgery Randomized Trial (Diabetes Surgery Study)
status: active
publisher: Computable Publishing LLC
contact: support@computablepublishing.com
description: Inclusion Criteria: Age 30 to 67 years at eligibility visit. Diagnosed with T2DM at least 6 months prior to enrollment, under the active care of a doctor for at least the six months prior to enrollment, and HbA1c ≥ 8.0%. Body Mass Index (BMI) ≥ 30.0 kg/m2 and ≤ 39.9 kg/m2 at eligibility visit. Willingness to accept random assignment to either treatment group. Expect to live or work within approximately one hour's traveling time from the study clinic for the duration of the two-year trial. Willingness to comply with the follow-up protocol and successful completion of the run-in. Written informed consent. ///// Exclusion Criteria: Cardiovascular event (myocardial infarction, acute coronary syndrome, coronary artery angioplasty or bypass, stroke) in the past six months. Current evidence of congestive heart failure, angina pectoris, or symptomatic peripheral vascular disease. Cardiac stress test indicating that surgery or IMM would not be safe. Pulmonary embolus or thrombophlebitis in the past six months. Cancer of any kind (except basal cell skin cancer or cancer in situ) unless documented to be disease-free for five years. Significant anemia (hemoglobin 1.0 g or more below normal range) or history of coagulopathy. Serum creatinine ≥ 1.5 mg/dl. HbA1c > 14.0%.
copyright: https://creativecommons.org/licenses/by-nc-sa/4.0/
effectivePeriod: 2008-02 --> 2016-12
author: Brian S. Alper:
actual: true
characteristic
description: Age 30 to 67 years at eligibility visit.
exclude: false
DefinitionByTypeAndValues
- Type Value[x] * Age (SNOMED CT#397669002) 30-67 years TimeFromEvents
- Description Event[x] Quantity * at eligibility visit EligibilityVisit 0
characteristic
description: Diagnosed with T2DM at least 6 months prior to enrollment, under the active care of a doctor for at least the six months prior to enrollment, and HbA1c ≥ 8.0%.
exclude: false
definitionByCombination
code: all-of
characteristic
description: Diagnosed with T2DM at least 6 months prior to enrollment
exclude: false
characteristic
description: under the active care of a doctor for at least the six months prior to enrollment
note: assumption that active care means active care of type 2 diabetes mellitus
exclude: false
definitionCodeableConcept: under the active care of a doctor (SNOMED CT#305450004 "Under care of doctor (finding)")
characteristic
description: HbA1c ≥ 8.0%
note: assumption that this is the last recorded HbA1c before the enrollment visit, but not explicitly stated in the short-phrase Eligibility Criteria
exclude: false
characteristic
description: Body Mass Index (BMI) ≥ 30.0 kg/m2 and ≤ 39.9 kg/m2 at eligibility visit.
exclude: false
DefinitionByTypeAndValues
- Type Value[x] * Body mass index (BMI) [Ratio] (LOINC#39156-5) 30-39.9 kg/m2 TimeFromEvents
- Description Event[x] Quantity * at eligibility visit EligibilityVisit 0
characteristic
description: Willingness to accept random assignment to either treatment group.
exclude: false
characteristic
description: Expect to live or work within approximately one hour's traveling time from the study clinic for the duration of the two-year trial.
exclude: false
characteristic
description: Willingness to comply with the follow-up protocol and successful completion of the run-in.
exclude: false
characteristic
linkId: EligibilityVisit
description: Written informed consent.
note: The example used here acknowledges attainment of the written informed consent at the eligibility visit (which is also the time of enrollment) so is referencing this characteristic with the linkId EligibilityVisit to be used as a reference point from timeFromEvent in the specification of other characteristics.
exclude: false
TimeFromEvents
- Event[x] * Assessment of eligibility for clinical trial (procedure) (SNOMED CT#450332002)
characteristic
description: Cardiovascular event (myocardial infarction, acute coronary syndrome, coronary artery angioplasty or bypass, stroke) in the past six months.
exclude: true
definitionByCombination
code: any-of
characteristic
description: myocardial infarction
characteristic
description: acute coronary syndrome
characteristic
description: coronary artery angioplasty or bypass
characteristic
description: stroke
TimeFromEvents
- Description Note Event[x] Range * in the past six months occurrence within the range is equivalent to 'in the past six months' EligibilityVisit -6-0 months
characteristic
description: Current evidence of congestive heart failure, angina pectoris, or symptomatic peripheral vascular disease.
note: This may be possible to encode as presence of Disease(disorder) without 'in remission'
exclude: true
characteristic
description: Cardiac stress test indicating that surgery or IMM would not be safe.
exclude: true
characteristic
description: Pulmonary embolus in the past six months.
exclude: true
DefinitionByTypeAndValues
- Type Value[x] * Disease (disorder) (SNOMED CT#64572001; resource-types#Condition "Condition") Pulmonary embolism (disorder) (SNOMED CT#59282003) TimeFromEvents
- Description Note Event[x] Range * in the past six months occurrence within the range is equivalent to 'in the past six months' EligibilityVisit -6-0 months
characteristic
description: Thrombophlebitis in the past six months.
exclude: true
DefinitionByTypeAndValues
- Type Value[x] * Disease (disorder) (SNOMED CT#64572001; resource-types#Condition "Condition") Thrombophlebitis (disorder) (SNOMED CT#64156001) TimeFromEvents
- Description Note Event[x] Range * in the past six months occurrence within the range is equivalent to 'in the past six months' EligibilityVisit -6-0 months
characteristic
description: Cancer of any kind (except basal cell skin cancer or cancer in situ) unless documented to be disease-free for five years.
exclude: true
definitionByCombination
code: all-of
characteristic
description: Cancer of any kind
exclude: false
characteristic
description: (except basal cell skin cancer)
exclude: true
characteristic
description: (except cancer in situ)
exclude: true
characteristic
description: unless documented to be disease-free for five years
exclude: true
definitionCodeableConcept: No evidence of cancer found (situation) (SNOMED CT#395100000)
characteristic
description: History of coagulopathy
exclude: true
characteristic
description: Significant anemia (hemoglobin 1.0 g or more below normal range)
exclude: true
DefinitionByTypeAndValues
- Type Value[x] Offset * Hemoglobin [Mass/volume] in Blood (LOINC#718-7) <=-1 g/dL (Details: UCUM code g/dL = 'g/dL') Lower Normal Limit (CharacteristicOffset#LNL)
characteristic
description: Serum creatinine ≥ 1.5 mg/dl
exclude: true
DefinitionByTypeAndValues
- Type Value[x] * Creatinine [Mass/volume] in Serum or Plasma (LOINC#2160-0) >=1.5 mg/dl (Details: UCUM code mg/dL = 'mg/dL')
characteristic
description: HbA1c ≥ 14.0%
exclude: true
DefinitionByTypeAndValues
- Type Value[x] * Hemoglobin A1c/Hemoglobin.total in Blood (LOINC#59261-8) >=14 % (Details: UCUM code % = '%')
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.